NuScale Power (NYSE: SMR) has seen its stock fall dramatically over the past year, yet valuation metrics suggest the beaten-down price does not represent a clear bargain for investors.
The share price has declined 72.8% over the past twelve months, reflecting a sharp and sustained reassessment of the company’s near-term commercial prospects by the broader market.
Despite that steep selloff, NuScale Power passes only one of six valuation checks under Simply Wall St’s framework, indicating the stock leans expensive rather than attractively priced.
Progress on securing a long-term power purchase agreement with the Tennessee Valley Authority has provided some support for expectations around future projects and commercial deployment timelines.
At the same time, a lawsuit over disclosures related to partner ENTRA1 continues to hang over the company, introducing meaningful uncertainty around execution risk and management credibility.
On a price-to-book basis, NuScale Power currently trades at approximately 2.9x book value, sitting very close to the Electrical industry average of roughly 2.7x, though well below the peer group average near 38.9x.
That positioning suggests the market is valuing NuScale Power’s equity base in line with the broader sector, neither assigning a meaningful premium for its small modular reactor technology nor a deep discount for its ongoing legal troubles.
Community narratives on the stock sit at opposite extremes, with a bull case arguing the stock is 36% undervalued and a bear case contending it is as much as 1,105% overvalued.
The bull argument centers on NuScale Power’s NRC-approved technology and more than $2 billion committed toward its development and licensing, positioning it for commercial deployment ahead of rivals still focused on demonstration plans.
The bear case points squarely at the ENTRA1 controversy and resulting fraud lawsuits, raising questions about whether management can execute on the commercial side as effectively as it did on the engineering side.
The central question for investors is whether NuScale Power can convert its regulatory approvals and potential contract wins into a durable, commercially proven business before legal and execution risks erode whatever valuation support remains at current prices.
With broader valuation checks remaining weak and the P/B multiple reflecting only ordinary sector pricing, the stock offers little margin of safety for investors betting on an early-stage nuclear energy story.
